These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 15875024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation.
    Zhang G, Zhou J, Fan Q, Zheng Z, Zhang F, Liu X, Hu S.
    FEBS Lett; 2008 Aug 20; 582(19):2957-64. PubMed ID: 18671974
    [Abstract] [Full Text] [Related]

  • 5. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.
    Seo S, Fujita H, Nakano A, Kang M, Duarte A, Kume T.
    Dev Biol; 2006 Jun 15; 294(2):458-70. PubMed ID: 16678147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of the nuclear gene encoding the alpha-subunit of the mammalian mitochondrial F1F0 ATP synthase complex: role for the orphan nuclear receptor, COUP-TFII/ARP-1.
    Jordan EM, Worley T, Breen GA.
    Biochemistry; 2003 Mar 11; 42(9):2656-63. PubMed ID: 12614160
    [Abstract] [Full Text] [Related]

  • 8. Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells.
    Korten S, Brunssen C, Poitz DM, Großklaus S, Brux M, Schnittler HJ, Strasser RH, Bornstein SR, Morawietz H, Goettsch W.
    Basic Res Cardiol; 2013 Jul 11; 108(4):362. PubMed ID: 23744056
    [Abstract] [Full Text] [Related]

  • 9. COUP-TFII is a major regulator of cell cycle and Notch signaling pathways.
    Chen X, Qin J, Cheng CM, Tsai MJ, Tsai SY.
    Mol Endocrinol; 2012 Aug 11; 26(8):1268-77. PubMed ID: 22734039
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
    van den Akker NM, Caolo V, Wisse LJ, Peters PP, Poelmann RE, Carmeliet P, Molin DG, Gittenberger-de Groot AC.
    Cardiovasc Res; 2008 May 01; 78(2):366-75. PubMed ID: 18093989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coup-TFII is up-regulated in adenovirus type 12 tumorigenic cells and is a repressor of MHC class I transcription.
    Smirnov DA, Hou S, Liu X, Claudio E, Siebenlist UK, Ricciardi RP.
    Virology; 2001 May 25; 284(1):13-9. PubMed ID: 11352663
    [Abstract] [Full Text] [Related]

  • 17. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.
    Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD.
    Dev Biol; 2001 Feb 15; 230(2):151-60. PubMed ID: 11161569
    [Abstract] [Full Text] [Related]

  • 18. BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.
    Davis RB, Curtis CD, Griffin CT.
    Development; 2013 Mar 15; 140(6):1272-81. PubMed ID: 23406903
    [Abstract] [Full Text] [Related]

  • 19. Arterial-venous specification during development.
    Swift MR, Weinstein BM.
    Circ Res; 2009 Mar 13; 104(5):576-88. PubMed ID: 19286613
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.